What happened during this study?
The participants were in the study for up to 4.3 months. But, the entire study
took nearly 2 years to finish.
The study started in June 2018 and was stopped earlier than planned in May
2020 because of the COVID-19 pandemic.
The chart below shows what happened during the study.
Before the participants took study treatment
1 or 2 visits
The study doctors: The participants:
checked the participants’ health to make took at least 1 type of RAAS inhibitor
sure they could join the study
did a physical exam and asked about
answered questionnaires about their
the participants’ medications and any
symptoms
medical problems
checked the participants’ heart health using
an electrocardiogram, also called an ECG
took blood and urine samples
2 weeks
While the participants took study treatment
5 or more visits
The study doctors: The participants:
did a physical exam and asked about took SZC or placebo
the participants’ medications and any
medical problems
took RAAS inhibitors depending on
took blood and urine samples
their blood potassium levels
12 weeks
After the participants took study treatment
3 visits
The study doctors: The participants:
did a physical exam and asked about took RAAS inhibitors depending on
the participants’ medications and any their blood potassium levels
medical problems
answered questionnaires about their
checked the participants’ heart health using
symptoms
an electrocardiogram, also called an ECG
took blood and urine samples
4 weeks
6 | Clinical Study Results